BACKGROUND AND AIM OF THE STUDY: The Authors report their implant's analysis and preliminary experience with a new fixation device, the MEDGAL DHS for treatment of proximal femoral fractures, producted by MEDGAL Sp.z o.o, Niewodnicka, Poland. MATERIALS: Between January 2019 and September 2019 in Orthopedics and Traumatology Department of Piacenza, 12 patients with stable pertrocanteric fractures were treated with the MEDGAL DHS. RESULTS: No patients presented perioperative complications with low bleeding and mean surgical time of 40 minutes. CONCLUSIONS: DHS is an optimal implant for the treatment of stable pertrochanteric femural fractures.
BACKGROUND AND AIM OF THE STUDY: The Authors report their implant's analysis and preliminary experience with a new fixation device, the MEDGAL DHS for treatment of proximal femoral fractures, producted by MEDGAL Sp.z o.o, Niewodnicka, Poland. MATERIALS: Between January 2019 and September 2019 in Orthopedics and Traumatology Department of Piacenza, 12 patients with stable pertrocanteric fractures were treated with the MEDGAL DHS. RESULTS: No patients presented perioperative complications with low bleeding and mean surgical time of 40 minutes. CONCLUSIONS:DHS is an optimal implant for the treatment of stable pertrochanteric femural fractures.
Authors: Pietro Maniscalco; Erika Poggiali; Fabrizio Quattrini; Corrado Ciatti; Andrea Magnacavallo; Andrea Vercelli; Marco Domenichini; Enrico Vaienti; Francesco Pogliacomi; Francesco Ceccarelli Journal: Acta Biomed Date: 2020-05-11